Detailed Information on Publication Record
2017
New probabilistic risk assessment of ethylhexyl methoxycinnamate: Comparing the genotoxic effects of trans- and cis-EHMC
SHARMA, Anežka, Katarína BÁNYIOVÁ, Jaromír LITERÁK and Pavel ČUPRBasic information
Original name
New probabilistic risk assessment of ethylhexyl methoxycinnamate: Comparing the genotoxic effects of trans- and cis-EHMC
Authors
SHARMA, Anežka (203 Czech Republic, belonging to the institution), Katarína BÁNYIOVÁ (703 Slovakia, belonging to the institution), Jaromír LITERÁK (203 Czech Republic, belonging to the institution) and Pavel ČUPR (203 Czech Republic, guarantor, belonging to the institution)
Edition
Environmental toxicology, Hoboken, USA, WILEY-BLACKWELL, 2017, 1520-4081
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10503 Water resources
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.491
RIV identification code
RIV/00216224:14310/17:00095508
Organization unit
Faculty of Science
UT WoS
000393799500019
Keywords in English
ethylhexyl methoxycinnamate; trans/cis isomerisation; genotoxicity; probabilistic risk assessment; QIVIVE
Tags
International impact, Reviewed
Změněno: 9/4/2018 16:26, Ing. Nicole Zrilić
Abstract
V originále
Ethylhexyl methoxycinnamate (EHMC) is a widely used UV filter present in a large number of personal care products (PCPs). Under normal conditions, EHMC occurs in a mixture of two isomers: trans-EHMC and cis-EHMC in a ratio of 99:1. When exposed to sunlight, the trans isomer is transformed to the less stable cis isomer and the efficiency of the UV filter is reduced. To date, the toxicological effects of the cis-EHMC isomer remain largely unknown. We developed a completely new method for preparing cis-EHMC. An EHMC technical mixture was irradiated using a UV lamp and 98% pure cis-EHMC was isolated from the irradiated solution using column chromatography. The genotoxic effects of the isolated cis-EHMC isomer and the nonirradiated trans-EHMC were subsequently measured using two bioassays (SOS chromotest and UmuC test). In the case of trans-EHMC, significant genotoxicity was observed using both bioassays at the highest concentrations (0.5 - 4 mgmL(-1)). In the case of cis-EHMC, significant genotoxicity was only detected using the UmuC test at concentrations of 0.25 - 1 mgmL(-1). Based on these results, the NOEC was calculated for both cis- and trans-EHMC, 0.038 and 0.064 mgmL(-1), respectively. Risk assessment of dermal, oral and inhalation exposure to PCPs containing EHMC was carried out for a female population using probabilistic simulation and by using Quantitative in vitro to in vivo extrapolation (QIVIVE). The risk of cis-EHMC was found to be approximate to 1.7 times greater than trans-EHMC. In the case of cis-EHMC, a hazard index of 1 was exceeded in the 92nd percentile. Based on the observed differences between the isomers, EHMC application in PCPs requires detailed reassessment. Further exploration of the toxicological effects and properties of cis-EHMC is needed in order to correctly predict risks posed to humans and the environment.
Links
GA14-27941S, research and development project |
| ||
LM2015051, research and development project |
| ||
LO1214, research and development project |
|